Literature DB >> 9371572

Rous sarcoma virus direct repeat cis elements exert effects at several points in the virus life cycle.

S B Simpson1, L Zhang, R C Craven, C M Stoltzfus.   

Abstract

Two approximately 135-nucleotide (nt) direct repeats flank the Rous sarcoma virus (RSV) oncogene src and are composed of two smaller repeats, dr1 (approximately 100 nt) and dr2 (approximately 36 nt). These sequences have been reported to contain cis-acting signals necessary for RNA packaging and elements that allow cytoplasmic accumulation of unspliced RNA (cytoplasmic transport elements). In this report, we show that avian fibroblasts infected with the Prague A strain of RSV with precise deletions of both dr1 elements express src and are transformed by this mutant virus but production of virus particles is very low and virus spread throughout the culture requires several weeks. We show that the replication defect is due to complex effects on viral RNA transport, viral RNA half-life, and virus particle assembly. The dr1 elements may contain binding sites for a permissive cell-specific factor(s) that facilitates efficient nuclear-cytoplasmic transport, RNA stability, and cytoplasmic utilization of unspliced viral RNA. The implications of these results for understanding the defects of nonpermissive virus infections in mammalian cells are discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9371572      PMCID: PMC230216     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

Review 1.  Dynamic interactions of the Gag polyprotein.

Authors:  R C Craven; L J Parent
Journal:  Curr Top Microbiol Immunol       Date:  1996       Impact factor: 4.291

2.  The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA.

Authors:  M H Malim; J Hauber; S Y Le; J V Maizel; B R Cullen
Journal:  Nature       Date:  1989-03-16       Impact factor: 49.962

3.  Nucleotide sequence of Rous sarcoma virus.

Authors:  D E Schwartz; R Tizard; W Gilbert
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

4.  Fibronectin receptors from Staphylococcus aureus.

Authors:  C Rydén; K Rubin; P Speziale; M Höök; M Lindberg; T Wadström
Journal:  J Biol Chem       Date:  1983-03-10       Impact factor: 5.157

5.  cis-Acting RNA packaging locus in the 115-nucleotide direct repeat of Rous sarcoma virus.

Authors:  J Sorge; W Ricci; S H Hughes
Journal:  J Virol       Date:  1983-12       Impact factor: 5.103

6.  Noncoding region between the env and src genes of Rous sarcoma virus influences splicing efficiency at the src gene 3' splice site.

Authors:  C M Stoltzfus; S K Lorenzen; S L Berberich
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

7.  Messenger RNA for myosin polypeptides: isolation from single myogenic cell cultures.

Authors:  R C Strohman; P S Moss; J Micou-Eastwood; D Spector; A Przybyla; B Paterson
Journal:  Cell       Date:  1977-02       Impact factor: 41.582

8.  Avian sarcoma virus gag precursor polypeptide is not processed in mammalian cells.

Authors:  V M Vogt; D A Bruckenstein; A P Bell
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

9.  Stabilities of avian sarcoma virus RNAs: comparison of subgenomic and genomic species with cellular mRNAs.

Authors:  C M Stoltzfus; K Dimock; S Horikami; T A Ficht
Journal:  J Gen Virol       Date:  1983-10       Impact factor: 3.891

10.  Monoclonal antibodies to Rous sarcoma virus pp60src react with enzymatically active cellular pp60src of avian and mammalian origin.

Authors:  S J Parsons; D J McCarley; C M Ely; D C Benjamin; J T Parsons
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

View more
  24 in total

1.  Point mutations in the avian sarcoma/leukosis virus 3' untranslated region result in a packaging defect.

Authors:  J M Aschoff; D Foster; J M Coffin
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Avian endogenous retrovirus EAV-HP shares regions of identity with avian leukosis virus subgroup J and the avian retrotransposon ART-CH.

Authors:  M A Sacco; D M Flannery; K Howes; K Venugopal
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

Review 3.  RNA processing control in avian retroviruses.

Authors:  Mark T McNally
Journal:  Front Biosci       Date:  2008-05-01

4.  Molecular events accompanying rous sarcoma virus rescue from rodent cells and the role of viral gene complementation.

Authors:  Anna Lounková; Eduarda Dráberová; Filip Šenigl; Katerina Trejbalová; Josef Geryk; Jirí Hejnar; Jan Svoboda
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

5.  Nuclear interactions are necessary for translational enhancement by spleen necrosis virus RU5.

Authors:  Andrew W Dangel; Stacey Hull; Tiffiney M Roberts; Kathleen Boris-Lawrie
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

6.  Genome structure and expression of the ev/J family of avian endogenous viruses.

Authors:  B L Ruis; S J Benson; K F Conklin
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

7.  Selective inhibition of splicing at the avian sarcoma virus src 3' splice site by direct-repeat posttranscriptional cis elements.

Authors:  W Guo; S C Winistorfer; C M Stoltzfus
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

8.  The 5' RNA terminus of spleen necrosis virus contains a novel posttranscriptional control element that facilitates human immunodeficiency virus Rev/RRE-independent Gag production.

Authors:  M Butsch; S Hull; Y Wang; T M Roberts; K Boris-Lawrie
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

9.  A new RNA element located in the coding region of a murine endogenous retrovirus can functionally replace the Rev/Rev-responsive element system in human immunodeficiency virus type 1 Gag expression.

Authors:  H Wodrich; J Bohne; E Gumz; R Welker; H G Kräusslich
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

10.  U1 small nuclear ribonucleoprotein and splicing inhibition by the rous sarcoma virus negative regulator of splicing element.

Authors:  L M McNally; M T McNally
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.